For instance, in KRAS-driven lung cancer, senescent macrophages accumulate in tumor tissues as tumors progress and depletion of senescent macrophages ameliorates tumorigenesis by enhancing immunosurveillance by effector T cells.55 The gene discussed is KRAS; the disease is neoplasm.